Innovative Models for High-Cost Medicines: A Comparative Analysis Across the U.S., Indonesia, and Asia

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This analysis reveals diverse financing mechanisms for high-cost medicines, highlighting affordability and equity across regions.

Innovative financing approaches reduced high-cost medicine expenditures while enhancing patient access in various countries.
Models like subscription-based pricing in the U.S. and bulk procurement in Indonesia demonstrate effective cost management strategies.
The use of health technology assessments in countries like Japan and South Korea aligns drug pricing with therapeutic value.
Expanding the policy toolkit can enhance affordability and equity in high-cost medicines globally, improving health outcomes.

Raymond R. Tjandrawinata (2025) studied this question.

View Full Paper

Ask AI

Bookmark